Medical oncologist Dr. R. Julie Brahmer discusses biomarker testing and advanced treatment for lung cancer patients.
Physicians and researchers at the Netherlands Cancer Institute have developed an AI model that outperforms physicians in evaluating treatment response in pleural mesothelioma. Far more accurate than ...
Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial Current predictive biomarkers for immune ...
dDepartment of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, China ...
Lung cancer is the leading cause of cancer-related mortality worldwide. Lately, electronic nose (e-nose) systems have emerged as a promising method for non-invasive lung cancer detection. These ...
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
Based on the health medical big data platform of Shandong University, we developed a VGG16-Based CNN lung cancer screening model. This model was trained using the Computed Tomography scans data of ...
Deep learning (DL) models predicting biomarker expression in images of hematoxylin and eosin (H&E)-stained tissues can improve access to multi-marker immunophenotyping, crucial for therapeutic ...
Abstract: Due to the large size and lack of fine-grained annotation, Whole Slide Images (WSIs) analysis is commonly approached as a Multiple Instance Learning (MIL) problem. However, previous studies ...
Somatic mutations are a hallmark of tumorigenesis and may be useful for non-invasive diagnosis of cancer. We analyzed whole-genome sequencing data from 2,511 individuals in the Pan-Cancer Analysis of ...
Copyright: © 2024 The Author(s). Published by Elsevier Ltd. The prognosis of lung carcinoma has changed since the discovery of molecular targets and their specific ...
This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...